domperidone has been researched along with Birth Weight in 5 studies
Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.
Birth Weight: The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The safety of domperidone in pregnancy remains unknown." | 7.79 | Fetal and neonatal outcomes in women taking domperidone during pregnancy. ( Ahn, HK; Choi, JS; Han, JY; Kim, MY; Koren, G; Nava-Ocampo, AA; Ryu, HM; Yang, JH, 2013) |
| "The safety of domperidone in pregnancy remains unknown." | 3.79 | Fetal and neonatal outcomes in women taking domperidone during pregnancy. ( Ahn, HK; Choi, JS; Han, JY; Kim, MY; Koren, G; Nava-Ocampo, AA; Ryu, HM; Yang, JH, 2013) |
| " Most women (80%) received directions to take domperidone according to a standard tapering dosing regimen over 12 days." | 1.39 | Audit of domperidone use as a galactogogue at an Australian tertiary teaching hospital. ( Gordon, AL; Grzeskowiak, LE; Lim, SW; Ritchie, U; Thomas, AE, 2013) |
| "A population pharmacokinetic analysis was performed to define domperidone pharmacokinetic parameters in preterm neonates, as no pharmacokinetic data are available in this population." | 1.35 | Population pharmacokinetics of domperidone in preterm neonates. ( Dailly, E; Drouineau, MH; Gournay, V; Jolliet, P; Rozé, JC, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, JS | 1 |
| Han, JY | 1 |
| Ahn, HK | 1 |
| Ryu, HM | 1 |
| Kim, MY | 1 |
| Yang, JH | 1 |
| Nava-Ocampo, AA | 1 |
| Koren, G | 1 |
| Grzeskowiak, LE | 2 |
| Dalton, JA | 1 |
| Fielder, AL | 1 |
| Dailly, E | 1 |
| Drouineau, MH | 1 |
| Gournay, V | 1 |
| Rozé, JC | 1 |
| Jolliet, P | 1 |
| Gounaris, A | 1 |
| Costalos, C | 1 |
| Varchalama, E | 1 |
| Kokori, F | 1 |
| Grivea, IN | 1 |
| Konstantinidi, K | 1 |
| Syrogiannopoulos, GA | 1 |
| Lim, SW | 1 |
| Thomas, AE | 1 |
| Ritchie, U | 1 |
| Gordon, AL | 1 |
1 trial available for domperidone and Birth Weight
| Article | Year |
|---|---|
Gastric emptying of preterm neonates receiving domperidone.
Topics: Antiemetics; Apgar Score; Birth Weight; Cross-Over Studies; Domperidone; Female; Gastric Emptying; G | 2010 |
4 other studies available for domperidone and Birth Weight
| Article | Year |
|---|---|
Fetal and neonatal outcomes in women taking domperidone during pregnancy.
Topics: Abnormalities, Drug-Induced; Adult; Antiemetics; Birth Weight; Domperidone; Female; Fetal Developmen | 2013 |
Factors associated with domperidone use as a galactogogue at an Australian tertiary teaching hospital.
Topics: Adult; Australia; Birth Weight; Breast Feeding; Cohort Studies; Domperidone; Dopamine Antagonists; D | 2015 |
Population pharmacokinetics of domperidone in preterm neonates.
Topics: Antiemetics; Birth Weight; Domperidone; Female; Gestational Age; Humans; Infant, Newborn; Infant, Pr | 2008 |
Audit of domperidone use as a galactogogue at an Australian tertiary teaching hospital.
Topics: Adult; Australia; Birth Weight; Domperidone; Dopamine Antagonists; Drug Utilization; Female; Galacto | 2013 |